Free Trial

AlphaQuest LLC Decreases Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Addus HomeCare logo with Medical background
Remove Ads

AlphaQuest LLC trimmed its holdings in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 91.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 930 shares of the company's stock after selling 10,333 shares during the quarter. AlphaQuest LLC's holdings in Addus HomeCare were worth $117,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of ADUS. Quarry LP purchased a new position in Addus HomeCare in the 3rd quarter worth approximately $28,000. Smartleaf Asset Management LLC lifted its stake in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after purchasing an additional 214 shares in the last quarter. Parkside Financial Bank & Trust lifted its stake in Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after purchasing an additional 148 shares in the last quarter. KBC Group NV lifted its stake in Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after purchasing an additional 268 shares in the last quarter. Finally, GAMMA Investing LLC lifted its stake in Addus HomeCare by 34.5% in the 4th quarter. GAMMA Investing LLC now owns 1,258 shares of the company's stock worth $158,000 after purchasing an additional 323 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on ADUS shares. Citizens Jmp raised shares of Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. Oppenheimer raised their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Macquarie restated an "outperform" rating and set a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. Stephens restated an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, JMP Securities started coverage on shares of Addus HomeCare in a report on Monday, December 16th. They set an "outperform" rating and a $150.00 price target for the company. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $132.78.

Remove Ads

Read Our Latest Stock Report on Addus HomeCare

Addus HomeCare Trading Down 1.2 %

Addus HomeCare stock traded down $1.07 during trading on Friday, hitting $89.83. The company had a trading volume of 434,769 shares, compared to its average volume of 148,784. Addus HomeCare Co. has a 1-year low of $87.88 and a 1-year high of $136.72. The company's 50 day simple moving average is $111.83 and its 200-day simple moving average is $121.87. The stock has a market cap of $1.63 billion, a price-to-earnings ratio of 20.56, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). The business had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the business's stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 4.60% of the company's stock.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Read More

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads